odoroside: obtained from Nerium oleander extract; structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Nerium | genus | A plant genus of the family APOCYNACEAE. It is a very poisonous plant that contains cardioactive agents.[MeSH] | Apocynaceae | The dogbane family of the order Gentianales. Members of the family have milky, often poisonous juice, smooth-margined leaves, and flowers in clusters.[MeSH] |
Nerium oleander | species | [no description available] | Apocynaceae | The dogbane family of the order Gentianales. Members of the family have milky, often poisonous juice, smooth-margined leaves, and flowers in clusters.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 165219 |
MeSH ID | M0372083 |
Synonym |
---|
brn 4729620 |
solanoside |
card-20(22)-enolide, 3-((6-deoxy-3-o-methyl-alpha-l-mannopyranosyl)oxy)- 14-hydroxy-, (3-beta,5-beta)- |
4356-33-6 |
3-[(3s,5r,8r,9s,10s,13r,14s,17r)-3-[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2h-furan-5-one |
odoroside |
card-20(22)-enolide, 3-[(6-deoxy-3-o-methyl-alpha-l-mannopyranosyl)oxy]-14-hydroxy-, (3beta,5beta)- |
DTXSID001318692 |
Odoroside A (OA) is an active ingredient extracted from the leaves of Nerium oleander Linn.
Excerpt | Reference | Relevance |
---|---|---|
"Odoroside A (OA) is an active ingredient extracted from the leaves of Nerium oleander Linn. " | ( Proteomic Analysis Reveals that Odoroside A Triggers G2/M Arrest and Apoptosis in Colorectal Carcinoma Through ROS-p53 Pathway. Chen, YY; Deng, CM; He, QY; Jiang, MM; Sun, ZH; Wen, SY; Yin, XF, 2019) | 2.24 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 1 (12.50%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (75.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |